Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis

Acta Dermato-Venereologica

Volumn 89, Issue 5, 2009, Pages 492-497

  Wolk, Katarina ^a   Mallbris, Lotus ^a   Larsson, Per ^a   Rosenblad, Andreas ^b   Vingård, Eva ^b   Ståhle, Mona ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Body mass index; Body weight; Plaque psoriasis; Psoriasis onset, severity; Smoking

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DISEASE ACTIVITY; DRINKING BEHAVIOR; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PSORIASIS VULGARIS; RISK FACTOR; SMOKELESS TOBACCO; SMOKING; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PSORIASIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; TOBACCO, SMOKELESS; WEIGHT GAIN; YOUNG ADULT;

EID: 70350175881     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0711     Document Type: Article

References (36)

1. Braathen LR, Botten G, Bjerkedal T. Prevalence of psoriasis in Norway. Acta Derm Venereol Suppl 1989; 142: 5-8.
2. Smith AE, Kassab JY, Rowland Payne CM, Beer WE. Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology 1993; 186: 181-186.
3. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141: 1537-1541. (Pubitemid 41815843)
4. Griffiths CE, Christophers E, Barker JN, Chalmers RJ, Chimenti S, Krueger GG, et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007; 156: 258-262. (Pubitemid 46095952)
5. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004; 51: 704-708. (Pubitemid 39516879)
6. Grjibovski AM, Olsen AO, Magnus P, Harris JR. Psoriasis in Norwegian twins: contribution of genetic and environmental effects. J Eur Acad Dermatol Venereol 2007; 21: 1337-1343. (Pubitemid 350020140)
7. Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-1534.
8. Hamminga EA, van der Lely AJ, Neumann HA, Thio HB. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006; 67: 768-773. (Pubitemid 44062144)
9. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-835. (Pubitemid 44556851)
10. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-328. (Pubitemid 44777680)
11. Braathen LR, Botten G, Bjerkedal T. Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venereol Suppl 1989; 142: 9-12.
12. Monk BE, Neill SM. Alcohol consumption and psoriasis. Dermatologica 1986; 173: 57-60.
13. Naldi L, Peli L, Parazzini F. Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. Arch Dermatol 1999; 135: 1479-1484.
14. Fortes C, Mastroeni S, Leffondre K, Sampogna F, Melchi F, Mazzotti E, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 2005; 141: 1580-1584. (Pubitemid 41815850)
15. Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med 2007; 120: 953-959. (Pubitemid 350011082)
16. Mills CM, Srivastava ED, Harvey IM, Swift GL, Newcombe RG, Holt PJ, et al. Smoking habits in psoriasis: a case control study. Br J Dermatol 1992; 127: 18-21.
17. Poikolainen K, Reunala T, Karvonen J. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 1994; 130: 473-477. (Pubitemid 24204666)
18. Poikolainen K, Reunala T, Karvonen J, Lauharanta J, Karkkainen P. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ 1990: 300: 780-783.
19. Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol 2000; 17: 174-178. (Pubitemid 30436592)
20. Marino MG, Carboni I, De Felice C, Maurici M, Maccari F, Franco E. Risk factors for psoriasis: a retrospective study on 501 outpatients clinical records. Ann Ig 2004; 16: 753-758.
21. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 2007; 167: 1670-1675. (Pubitemid 47280349)
22. Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005; 125: 61-67. (Pubitemid 40981424)
23. Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559-1565. (Pubitemid 350277774)
24. Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 2005; 210: 194-199. (Pubitemid 40529233)
25. Fogarty AW, Glancy C, Jones S, Lewis SA, McKeever TM, Britton JR. A prospective study of weight change and systemic inflammation over 9 y. Am J Clin Nutr 2008; 87: 30-35.
26. Makrygiannakis D, af Klint E, Lundberg IE, Lofberg R, Ulfgren AK, Klareskog L, et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis 2006; 65: 1219-1222.
27. Mallbris L, Larsson P, Bergqvist S, Vingård E, Granath F, Ståhle M. Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases. J Invest Dermatol 2005; 124: 499-504. (Pubitemid 40381571)
28. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244. (Pubitemid 8387357)
29. Berth-Jones J, Grotzinger K, Rainville C, Pham B, Huang J, Daly S, et al. A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. Br J Dermatol 2006; 155: 707-713. (Pubitemid 44352550)
30. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i-xii, 1-253.
31. Rothman KJ. Modern Epidemiology. Boston: Little, Brown & Co; 1986; p. 279-280.
32. Brant R. Assessing proportionality in the proportional odds model for ordinal logistic regression. Biometrics 1990; 46: 1171-1178.
33. Christensen TE, Callis KP, Papenfuss J, Hoffman MS, Hansen CB, Wong B, et al. Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes. J Invest Dermatol 2006; 126: 2397-2403. (Pubitemid 44582260)
34. de la Maza MP, Olivares D, Hirsch S, Sierralta W, Gattas V, Barrera G, et al. Weight increase and overweight are associated with DNA oxidative damage in skeletal muscle. Clin Nutr 2006; 25: 968-976. (Pubitemid 44780617)
35. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-873.
36. Francus T, Romano PM, Manzo G, Fonacier L, Arango N, Szabo P. IL-1, IL-6, and PDGF mRNA expression in alveolar cells following stimulation with a tobacco-derived antigen. Cell Immunol 1992; 145: 156-174.